CREDIT SUISSE AG/ - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 122 filers reported holding CARIBOU BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q1 2024$57,619
-10.3%
11,2100.0%0.00%
Q4 2023$64,233
-11.5%
11,210
-26.2%
0.00%
Q3 2023$72,599
-76.8%
15,188
-74.2%
0.00%
Q1 2023$312,558
-4.3%
58,862
+13.2%
0.00%
Q4 2022$326,662
-11.2%
52,016
+48.6%
0.00%
Q3 2022$368,000
+107.9%
34,996
+7.2%
0.00%
Q2 2022$177,000
+2.9%
32,636
+74.4%
0.00%
Q1 2022$172,000
-30.4%
18,715
+13.7%
0.00%
Q4 2021$247,00016,4630.00%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q2 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 544,196$5,741,00019.52%
Elmwood Wealth Management, Inc. 2,364,240$24,943,00012.45%
72 Investment Holdings, LLC 474,067$5,001,0003.96%
PFM Health Sciences, LP 6,000,000$63,300,0002.29%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 257,892$2,716,0000.87%
Avidity Partners Management LP 3,172,600$33,471,0000.68%
Rokos Capital Management LLP 1,907,509$20,811,0000.62%
Green Alpha Advisors, LLC 69,376$732,0000.62%
Nelson Capital Management, LLC 85,020$897,0000.26%
Tekla Capital Management LLC 567,147$5,983,0000.24%
View complete list of CARIBOU BIOSCIENCES INC shareholders